Dr. Zhe Hu is working at the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences. She serves as a Council Member of the Equine Science Branch of the Chinese Association of Animal Science and Veterinary Medicine (CAAV). Her primary research focuses on the diagnosis, immunology, and epidemiology of significant infectious diseases in equids, as well as the development of related diagnostic reagents.

She has led one National Natural Science Foundation of China (NSFC) Youth Project, two sub-projects of the National Key Research and Development Program, one National Standard Revision Project, and one National Standard Sample Development Project. Additionally, She has participated in four international projects, including the WOAH Twinning projects on equine influenza and equine infectious anemia. She has developed over 30 diagnostic reagent products for major equine infectious diseases such as equine infectious anemia, Glanders, equine influenza, Salmonella Abortusequi and so on. More than 10 diagnostic reagents developed by her have been applied for national new veterinary drug registration, and one of them has been approved for a national second-class new veterinary drug certificate. She holds nine national invention patents. The "Equine Infectious Anemia Virus cELISA Antibody Test Kit" she developed has been recommended as a key technology in the Ministry of Agriculture and Rural Affairs' "Equine Infectious Anemia Eradication Plan." She has published more than 20 SCI papers in internationally renowned academic journals such as Journal of Virology, Transboundary and Emerging Diseases, International Journal of Biological Macromolecules, and Microbiology Spectrum. She has also co-authored three monographs. In 2019, she was honored as an advanced worker in science and technology in China's horse industry and was awarded the "Bole" prize.